Disruptive Capital GP
Status
ACTIVE
Global HQ
St Peter Port, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Seed
Industries
- Fintech
- AI
- Blockchain
- Cryptocurrency
- Data Science
About
Disruptive Capital GP is a London-based Private Equity firm renowned for its expertise in sourcing and managing opportunistic investments across diverse sectors and stages of development. The firm is dedicated to identifying and capitalizing on market dislocations and complex opportunities, employing a strategic approach that combines rigorous analysis with innovative thinking. By leveraging a deep understanding of industry dynamics and market trends, Disruptive Capital aims to unlock substantial value for its investors while driving significant growth for its portfolio companies. Committed to fostering long-term partnerships, the firm is positioned to navigate the ever-evolving investment landscape with agility and insight.
Disruptive Capital GP is a London-based Private Equity firm renowned for its expertise in sourcing and managing opportunistic investments across diverse sectors and stages of development. The firm is dedicated to identifying and capitalizing on market dislocations and complex opportunities, employing a strategic approach that combines rigorous analysis with innovative thinking. By leveraging a deep understanding of industry dynamics and market trends, Disruptive Capital aims to unlock substantial value for its investors while driving significant growth for its portfolio companies. Committed to fostering long-term partnerships, the firm is positioned to navigate the ever-evolving investment landscape with agility and insight.
Investment Thesis
They unlock value from market dislocations and complex opportunities, investing across a broad range of sectors and stages. This strategy has delivered a 33% IRR on all realised investments over 27 years.
Manager's Experience
With extensive experience in venture capital, the fund manager has successfully navigated diverse sectors, including technology and healthcare, focusing primarily on early to growth-stage investments. Active across North America and Europe, they have completed over 30 deals, positioning themselves as a data-driven strategist. Their portfolio boasts notable exits, illustrating a strong track record in identifying high-potential companies. Emphasizing an operator-first approach, they leverage industry insights to drive value and foster innovation within their investments.
Team
Jeffrey Belkin
CA£Â©Driane De Boucaud
Catarina S
Rachel Bradshaw
Olivia Bloomfield